In a double-blind trial undertaken in 183 centres in 14 European countries over 48 weeks , patients ( aged 18 years ) with asthma that was not fully controlled , with a forced expiratory volume in 1 s ( FEV1 ) of at least 60 % predicted , had a 2-week run in .